Earnings History Data for Sutro Biopharma (STRO) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Sutro Biopharma

Sutro Biopharma Inc. develops and manufactures pharmaceutical products. The Company provides antibody drug conjugate and multi-specific antibody-based therapeutics for cancer therapy. Its product pipeline consists of STRO-001 and STRO-002 which are in clinical stage. Sutro Biopharma Inc. is based in South San Francisco, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
13-11-2024	AH		STRO	Sutro Biopharma	361.00	-0.59	-0.74	0.00	Sutro Biopharma GAAP EPS of -$0.59 beats by $0.14, revenue of $8.5M misses by $6.76M [11/13/2024 6:01 PM]	3.46	-0.50 (-12.75%)	3.96	0.0 (0.00%)	2.06 - 6.13	625,641	640,000	14,202
Sutro Biopharma GAAP EPS of -$0.59 beats by $0.14, revenue of $8.5M misses by $6.76M [11/13/2024 6:01 PM] Sutro Biopharma Reports Third Quarter 2024 Financial Results and Business Highlights [2024-11-13 04:30PM]
13-08-2024	AH		STRO	Sutro Biopharma	255.00	-0.59	-0.76	0.00	Sutro Biopharma GAAP EPS of -$0.59, revenue of $25.7M [8/14/2024 10:40 AM]	3.58	0.36 (11.18%)	3.30	0.08 (2.48%)	2.01 - 6.13	625,106	550,000	126
Sutro Biopharma GAAP EPS of -$0.59, revenue of $25.7M [8/14/2024 10:40 AM]
13-05-2024	AH		STRO	Sutro Biopharma	272.00	-0.95	-0.92	0.00	Sutro Biopharma GAAP EPS of -$0.95, revenue of $13M [5/13/2024 5:18 PM]	4.34	0.11 (2.72%)	4.31	0.08 (1.89%)	2.01 - 6.13	458,116	660,000	545
Sutro Biopharma GAAP EPS of -$0.95, revenue of $13M [5/13/2024 5:18 PM]
25-03-2024	PM		STRO	Sutro Biopharma	213.00	0.42	-0.82	0.00	Sutro Biopharma GAAP EPS of -$1.78 beats by $1.31, revenue of $153.73M beats by $101.4M [3/26/2024 2:02 AM]	4.17	0.90 (27.52%)	3.85	0.58 (17.74%)	2.01 - 6.11	2,986,720	960,000	91,211
Sutro Biopharma GAAP EPS of -$1.78 beats by $1.31, revenue of $153.73M beats by $101.4M [3/26/2024 2:02 AM]
13-11-2023	AH		STRO	Sutro Biopharma	136.00	-0.81	-0.76	0.00	Sutro Biopharma GAAP EPS of -$0.81, revenue of $16.9M [11/13/2023 5:41 PM]	2.34	0.27 (13.04%)	2.09	0.02 (0.97%)	2.01 - 8.72	1,170,647	530,000	9,327
Sutro Biopharma GAAP EPS of -$0.81, revenue of $16.9M [11/13/2023 5:41 PM] Sutro Biopharma files for $300M mixed shelf [11/13/2023 5:36 PM]
10-08-2023	PM		STRO	Sutro Biopharma	248.00	-0.64	-0.73	0.00	Sutro Biopharma GAAP EPS of -$0.64 beats by $0.07, revenue of $10.4M misses by $3.2M [8/11/2023 4:02 AM]	4.25	-0.09 (-2.07%)	4.34	0.0 (0.00%)	4.06 - 8.72	176,220	180,000	5,491
Sutro Biopharma GAAP EPS of -$0.64 beats by $0.07, revenue of $10.4M misses by $3.2M [8/11/2023 4:02 AM]
30-03-2023	PM	4:30 PM ET (Mar 30)	STRO	Sutro Biopharma	264.00	-0.61	-0.64	0.00	Sutro Biopharma GAAP EPS of -$2.35 beats by $0.16, revenue of $67.8M misses by $0.57M [3/31/2023 12:50 AM]	4.60	0.12 (2.68%)	4.48	0.0 (0.00%)	3.33 - 9.16	499,472	650,000	14,370
Sutro Biopharma GAAP EPS of -$2.35 beats by $0.16, revenue of $67.8M misses by $0.57M [3/31/2023 12:50 AM]
08-11-2022	AH	4:30 PM ET (Nov 8)	STRO	Sutro Biopharma	383.00	-0.37	-0.15	0.00	Sutro Biopharma GAAP EPS of -$0.37 misses by $0.08, revenue of $25.14M misses by $10.62M [11/8/2022 5:11 PM]	7.37	0.22 (3.08%)	7.19	0.04 (0.56%)	3.33 - 22.02	274,868	320,000	119
Sutro Biopharma GAAP EPS of -$0.37 misses by $0.08, revenue of $25.14M misses by $10.62M [11/8/2022 5:11 PM] Sutro Biopharma Reports Third Quarter 2022 Financial Results, Business Highlights and Select Anticipated Milestones [Nov-08-22 04:30PM]
10-11-2021	PM		STRO	Sutro Biopharma	996.00	-0.67	-0.67	0.00	Sutro Biopharma EPS misses by $0.02, misses on revenue [11/10/2021 8:45 AM]	21.58	-0.01 (-0.04%)	0.0	0.0 (0.00%)	14.69 - 28.30	188,047	170,000	0
Sutro Biopharma EPS misses by $0.02, misses on revenue [11/10/2021 8:45 AM] Sutro Biopharma, Inc. (STRO) Reports Q3 Loss, Misses Revenue Estimates [Nov-10-21 08:55AM] Sutro Biopharma Reports Third Quarter 2021 Financial Results, Business Highlights, and Anticipated 2021 Milestones [Nov-10-21 07:00AM]
09-08-2021	PM	7:00 AM ET (Aug 9)	STRO	Sutro Biopharma, Inc.	855.00	-0.13	-0.42	0.00	Sutro Biopharma reports Q2 results [8/9/2021 7:27 AM]	18.38	-0.08 (-0.43%)	18.40	-0.06 (-0.33%)	8.25 - 28.30	359,818	290,000	100
Sutro Biopharma reports Q2 results [8/9/2021 7:27 AM] Sutro Biopharma Reports Second Quarter 2021 Financial Results, Business Highlights and Anticipated Second Half 2021 Milestones [Aug-09-21 07:05AM] Sutro Biopharma Appoints Jane Chung as Chief Commercial Officer [Aug-09-21 07:00AM] Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Tops Revenue Estimates [Aug-09-21 08:35AM]
07-05-2021	PM		STRO	Sutro Biopharma, Inc.	894.00	-0.43	-0.61	0.00	Sutro Biopharma EPS misses by $0.04, beats on revenue [5/7/2021 7:42 AM]	19.29	0.77 (4.16%)	19.29	0.0 (0.00%)	7.06 - 28.30	182,844	280,000	6,539
Sutro Biopharma EPS misses by $0.04, beats on revenue [5/7/2021 7:42 AM] Sutro Biopharma Reports First Quarter 2021 Financial Results, Business Highlights and 2021 Anticipated Milestones [May-07-21 07:00AM] Sutro Biopharma, Inc. (STRO) Reports Q1 Loss, Tops Revenue Estimates [May-07-21 08:25AM]
18-03-2021	PM	7:00 AM ET (Mar 18)	STRO	Sutro Biopharma, Inc.	913.00	-1.48	-0.56	0.00	Sutro Biopharma EPS misses by $1.07, revenue in-line [3/18/2021 7:49 AM]	24.06	0.10 (0.42%)	22.77	-1.19 (-4.97%)	6.00 - 28.30	658,356	480,000	748
Sutro Biopharma EPS misses by $1.07, revenue in-line [3/18/2021 7:49 AM] Sutro Biopharma Reports Full Year 2020 Financial Results and Provides Business Highlights and 2021 Anticipated Milestones [Mar-18-21 07:00AM] Sutro Biopharma, Inc. (STRO) Reports Q4 Loss, Lags Revenue Estimates [Mar-18-21 08:35AM]